Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhNRG-1 for Chronic Systolic Heart Failure (Phase III)
ChiCTR-TRC-10000890Phase 3Suspended
- Sponsor
- Fuwai Hospital
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure with reduced ejection fraction (HFrEF) comparing rhNRG-1 with Placebo (2 arms). Primary endpoint: All-cause mortality. Started Apr 2010; status: suspended.
02
Drugs
neucardin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on ChiCTR-TRC-10000890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000890.